By Elaine Sarkin Jaffe, MD, Daniel A. Arber, MD, Elias Campo, MD, Leticia Quintanilla-Fend, MD, Attilio Orazi, MD, Lisa M. Rimsza, MD and Steven H. Swerdlow, MD
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, r
...view more
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**
Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, remains your #1 source of authoritative information in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a wealth of up-to-date information in an easily accessible format, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this highly illustrated, practical text is a must-have resource for residents and practicing pathologists alike.
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**
Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, remains your #1 source of authoritative information in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a wealth of up-to-date information in an easily accessible format, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this highly illustrated, practical text is a must-have resource for residents and practicing pathologists alike.
Key Features
Helps you navigate the latest changes in the classification of hematolymphoid neoplasms, providing guidance for use of both the International Consensus Classification (ICC) and 5th edition of the WHO classification
Incorporates the latest molecular/cytogenetic information, regarding newly recognizedentities and the latest diagnostic criteria
Provides you with today's most effective guidance in evaluating specimens from the lymph nodes, bone marrow, peripheral blood, and more, with authoritative information on the pathogenesis, clinical and pathologic diagnosis, and treatment for each
Details the latest insights on the molecular biology of benign and malignant hematologic disorders
Features more than 1,100 high-quality color images that mirror the findings you encounter in practice
Uses an easy-to-navigate, templated format with standard headings in each chapter.
Includes information on disease progression and prognosis, helping you better understand the clinical implications of diagnosis
Shares the knowledge and expertise of new editors, Drs. Lisa Rimsza, Attilio Orazi, and Steven Swerdlow, providing expertise in molecular diagnostics, bone marrow and lymph node biopsies
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
Author Information
By Elaine Sarkin Jaffe, MD, Chief, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Clinical Professor of Pathology, George Washington University School of Medicine; Series Editor, World Health Organization Classification of Tumours 4th Edition, International Agency for Research on Cancer, Bethesda, Maryland, USA; Daniel A. Arber, MD, Professor and Chair of Pathology, University of Chicago School of Medicine, USA; Elias Campo, MD, Chief, Hematopathology Unit, Professor of Anatomic Pathology, Clinical Director, Center for Biomedical Diagnosis, Hospital Clinic, University of Barcelona, Barcelona, Spain; Leticia Quintanilla-Fend, MD, Associate Professor, Institute of Pathology, Eberhard-Karls-University; Senior Staff, Institute of Pathology, University Hospital and Comprehensive Cancer Center, Tübingen, Germany; Attilio Orazi, MD, Chair, Department of Pathology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA; Lisa M. Rimsza, MD, Department of Pathology, Mayo Clinic, USA and Steven H. Swerdlow, MD, Professor of Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
By Elaine Sarkin Jaffe, MD, Chief, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Clinical Professor of Pathology, George Washington University School of Medicine; Series Editor, World Health Organization Classification of Tumours 4th Edition, International Agency for Research on Cancer, Bethesda, Maryland, USA; Daniel A. Arber, MD, Professor and Chair of Pathology, University of Chicago School of Medicine, USA; Elias Campo, MD, Chief, Hematopathology Unit, Professor of Anatomic Pathology, Clinical Director, Center for Biomedical Diagnosis, Hospital Clinic, University of Barcelona, Barcelona, Spain; Leticia Quintanilla-Fend, MD, Associate Professor, Institute of Pathology, Eberhard-Karls-University; Senior Staff, Institute of Pathology, University Hospital and Comprehensive Cancer Center, Tübingen, Germany; Attilio Orazi, MD, Chair, Department of Pathology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA; Lisa M. Rimsza, MD, Department of Pathology, Mayo Clinic, USA and Steven H. Swerdlow, MD, Professor of Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
PART I Technical Aspects 1. Processing of the Lymph Node Biopsy Specimen 2. Fine-Needle Aspiration of Lymph Nodes 3. Immunohistochemistry for the Hematopathology Laboratory 4. Flow Cytometry 5. Molecular Pathology of Hematologic Neoplasms 6. Important Chromosomal Aberrations in Hematologic Neoplasms and Key Techniques to Diagnose Them
PART II Normal and Reactive Conditions of Hematopoietic Tissues 7. Normal Lymphoid Organs and Tissues 8. Reactive Lymphadenopathies 9. The Normal Bone Marrow 10. Evaluation of Anemia, Leukopenia, and Thrombocytopenia 11. Bone Marrow Findings in Inflammatory, Infectious, and Metabolic Disorders
PART III Lymphoid Neoplasms 12. Principles of Classification of Lymphoid Neoplasms
SECTION 1 • MATURE B-CELL NEOPLASMS 13. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Monoclonal B-Cell Lymphocytosis, and B-Cell Prolymphocytic Leukemia 14. Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia 15. Hairy Cell Leukemia 16. Splenic Marginal Zone Lymphoma and Other Small B-Cell Neoplasms in the Spleen 17. Follicular Lymphoma 18. Extranodal Marginal Zone Lymphoma: MALT Lymphoma 19. Primary Cutaneous B-Cell Lymphomas 20. Nodal Marginal Zone Lymphoma 21. Mantle Cell Lymphoma 22. Aggressive B-Cell Lymphomas Including Diffuse Large B-Cell Lymphoma, Not Otherwise Specified and Other Nodal and Extranodal Large B-Cell Lymphomas 23. Burkitt Lymphoma, High-Grade B-Cell Lymphoma Not Otherwise Specified, High-Grade B-Cell Lymphoma With MYC and BCL2/BCL6 Rearrangements, Large B-Cell Lymphoma With 11q Aberration, and Provisional Entity High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements 24. Plasmablastic Neoplasms Other Than Plasma Cell Myeloma 25. Plasma Cell Neoplasms 26. Nodular Lymphocyte-Predominant B-Cell Lymphoma 27. Classic Hodgkin Lymphoma 28. Virally Associated B-Cell Lymphoproliferative Disease
SECTION 2 • MATURE T-CELL AND NK-CELL NEOPLASMS 29. Epstein-Barr Virus–Associated T-Cell and Natural Killer–Cell Lymphoproliferative Disorders 30. T-Cell and NK-Cell Large Granular Lymphocyte Proliferations 31. T-Cell Prolymphocytic Leukemia 32. Adult T-Cell Leukemia/Lymphoma 33. Hepatosplenic T-Cell Lymphoma 34. Peripheral T-Cell Lymphoma, Not Otherwise Specified 35. Follicular Helper T-Cell Lymphoma 36. Anaplastic Large Cell Lymphoma, ALK Positive and ALK Negative 37. Enteropathy-Associated T-Cell Lymphoma and Other Primary Intestinal T-Cell Lymphomas 38. Mycosis Fungoides and Sézary Syndrome 39. Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders 40. Primary Cutaneous T-Cell Lymphomas: Rare Subtypes
SECTION 3 • PRECURSOR B- AND T-CELL NEOPLASMS 41. Precursor B-Cell and T-Cell Neoplasms 42. Acute Leukemias of Ambiguous Lineage
PART IV Myeloid, Histiocytic, and Related Proliferations 43. Principles of Classification of Myeloid Neoplasms 44. The Myelodysplastic Syndromes 45. Myeloid and Hematologic Neoplasms With Germline Predisposition 46. Acute Myeloid Leukemia 47. Myeloproliferative Neoplasms 48. Myelodysplastic/Myeloproliferative Neoplasms and Premalignant Conditions 49. Mastocytosis 50. Eosinophilia, Chronic Eosinophilic Leukemia, Not Otherwise Specified, and Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions 51. Blastic Plasmacytoid Dendritic Cell Neoplasm 52. Histiocytic and Dendritic Cell Proliferations—Systemic and Neoplastic
PART V Immunodeficiency Disorders 53. The Pathology of Primary Immunodeficiencies 54. Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
PART VI Site-Specific Issues in the Diagnosis of Lymphoma and Leukemia 55. Bone Marrow Evaluation for Lymphoma 56. Evaluation of the Bone Marrow After Therapy 57. Non-hematopoietic Neoplasms and Other Lesions of the Bone Marrow and Lymph Nodes 58. Spleen: Normal Architecture and Neoplastic and Non-neoplastic Lesions 59. Diagnosis of Lymphoma in Extranodal Sites Other Than Skin
APPENDIX A: THE INTERNATIONAL CONSENSUS CLASSIFICATION OF MYELOID, LYMPHOID, AND HISTIOCYTIC NEOPLASMS
https://www.elsevierhealth.com.au/hematopathology-9780323831659.html313500Hematopathologyhttps://www.elsevierhealth.com.au/media/catalog/product/9/7/9780323831659_6.jpg380.96507.95AUDInStock/Medicine/Pathology/Medicine/Pathology/Books/Books/Japan Titles/Medicine & Surgery/Pathology/Books/Bestsellers505455652598365054664525503952631604335091438872250613771488653650545535145120525983341826924335088**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**<BR><BR>Covering the broad range of benign and malignant disorders that affect the hematopoietic system, <i>Hematopathology, 3rd Edition</i>, remains <b>your #1 source of authoritative information</b> in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a <b>wealth of up-to-date information in an easily accessible format</b>, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this <b>highly illustrated, practical text</b> is a must-have resource for residents and practicing pathologists alike. **Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**<BR><BR>Covering the broad range of benign and malignant disorders that affect the hematopoietic system, <i>Hematopathology, 3rd Edition</i>, remains <b>your #1 source of authoritative information</b> in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a <b>wealth of up-to-date information in an easily accessible format</b>, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this <b>highly illustrated, practical text</b> is a must-have resource for residents and practicing pathologists alike.00add-to-cart97803238316592024ProfessionalBy Elaine Sarkin Jaffe, MD, Daniel A. Arber, MD, Elias Campo, MD, Leticia Quintanilla-Fend, MD, Attilio Orazi, MD, Lisa M. Rimsza, MD and Steven H. Swerdlow, MD20253Book216w x 276h (8.50" x 10.875")Approx. 2260 illustrations (2200 in full color)Elsevier12964 Sep 2024IN STOCKBy <STRONG>Elaine Sarkin Jaffe</STRONG>, MD, Chief, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Clinical Professor of Pathology, George Washington University School of Medicine; Series Editor, World Health Organization Classification of Tumours 4th Edition, International Agency for Research on Cancer, Bethesda, Maryland, USA; <STRONG>Daniel A. Arber</STRONG>, MD, Professor and Chair of Pathology, University of Chicago School of Medicine, USA; <STRONG>Elias Campo</STRONG>, MD, Chief, Hematopathology Unit, Professor of Anatomic Pathology, Clinical Director, Center for Biomedical Diagnosis, Hospital Clinic, University of Barcelona, Barcelona, Spain; <STRONG>Leticia Quintanilla-Fend</STRONG>, MD, Associate Professor, Institute of Pathology, Eberhard-Karls-University; Senior Staff, Institute of Pathology, University Hospital and Comprehensive Cancer Center, Tübingen, Germany; <STRONG>Attilio Orazi</STRONG>, MD, Chair, Department of Pathology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA; <STRONG>Lisa M. Rimsza</STRONG>, MD, Department of Pathology, Mayo Clinic, USA and <STRONG>Steven H. Swerdlow</STRONG>, MD, Professor of Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USABooksBookUnited StatesYesYesNoNoPlease SelectPlease SelectPlease Select
